Current Chief Financial Officer and Treasurer · ADMA BIOLOGICS, INC. (ADMA)

Paul Kohler

FY2025 is the first fiscal year CompBrief holds for Paul Kohler as a named executive officer of ADMA BIOLOGICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,296,949

Compensation figures as of the proxy filed April 15, 2026 (DEF 14A).

Paul Kohler compensation by year

ADMA BIOLOGICS Summary Compensation Table · the one fiscal year held
In US dollars, as ADMA BIOLOGICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$19,231
Bonus$0
Stock awards$1,124,988
Option awards$1,124,988
Non-equity incentive$15,750
Pension and deferred compensation$0
All other$11,992
Total$2,296,949

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ADMA BIOLOGICS, INC. DEF 14A filed April 15, 2026, accession 0001140361-26-014799, and prior-year filings. Open the filing on EDGAR.

ADMA BIOLOGICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Adam GrossmanPresident, Chief Executive Officer and Director$10,237,326
Kaitlin KestenbergChief Operating Officer & Senior Vice President, Compliance$3,488,647
Brad TadeFormer Executive Vice President and Chief Financial Officer$2,823,630
Paul Kohler · this pageCurrent Chief Financial Officer and Treasurer$2,296,949

The full ADMA BIOLOGICS compensation record

free company brief

This page is one person within ADMA BIOLOGICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ADMA BIOLOGICS's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ADMA BIOLOGICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy